For Companies and Institutions
Key Links
For Institutional Investors
Putting our long-tenured investment teams on the line to earn the trust of institutional investors.
Direct access to market leading liquidity harnessed through world-class research, tools, data, and analytics.
Helping institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of a rapidly evolving market.
Leveraging cutting-edge technology and innovative tools to bring clients industry-leading analysis and investment advice.
Helping hedge funds, asset managers and institutional investors meet the demands of a rapidly evolving market.
Global short-term fixed income strategies designed to help clients manage liquidity through the cycle.
Key Links
For Individuals
For Employers
Enhance your equity compensation offering with solutions designed to empower your employees and bring your reward strategy to life.
Key Links
Who We Serve
Key Links
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
Effective and safe therapies for neurological diseases are practically nonexistent. Montara is changing that. J.P. Morgan's expertise in life sciences drew us to them as the obvious choice for Montara Therapeutics. Early in the company's history, we had this really critical inflection point. And the J.P. Morgan team gave us the security and support to allow us to focus on the science. Working with J.P. Morgan provided us with the clarity to move from early science to a scalable platform. It could help us make a real difference in patients' lives.
Montara Therapeutics is developing more effective therapies for neurological diseases to improve patient outcomes. The team sought secure, expert business support—so they could focus on the science that drives progress in medicine.
Working with J.P. Morgan, Montara Therapeutics gained the strategic support to build a platform that delivers safer, more effective therapies for people with neurological diseases.
“Working with J.P. Morgan provided us with the clarity to move from early science to a scalable platform. It could help us make a real difference in patients' lives.”
—Nicholas Hertz, Founder and CEO, Montara
Whether you’re building a life sciences startup or preparing for public launch, we can help you reach your next milestone. Connect with J.P. Morgan Startup Banking today, and explore our Innovation Economy content hub for more insights.
JPMorgan Chase Bank, N.A. Member FDIC. Visit jpmorgan.com/commercial-banking/legal-disclaimer for disclosures and disclaimers related to this content.
Banking
Healthcare markets outlook: A “dynamic” landscape ripe for M&A deals and cross-border partnerships
Jun 26, 2026
In spite of macro uncertainty, dealmaking in healthcare remains active, with capital following differentiated innovation, scalable platforms, resilient business models — and, of course, AI.
Banking
AI, defense and IPOs drive industrial innovation
Jun 25, 2026
Rapid advances in artificial intelligence, rising global defense budgets and shifting investment patterns are transforming industries.
Banking
Cybersecurity in the age of artificial intelligence
Jun 25, 2026
AI is both the threat and the defense. Explore where venture capital is concentrating and what enterprise buyers expect from the next wave of security solutions.
Banking
Treasurers in Europe shift priorities: Polling data highlights evolving strategies amid volatility
Jun 22, 2026
New polling from treasury leaders in Europe, the U.K. and the Middle East signals how corporate treasurers are recalibrating risk, managing liquidity and building digital roadmaps for the rest of 2026.
2:09 - Banking
Building a beauty brand that empowers women: Maison 276
Jun 15, 2026
Angel and Keith Cornelius share how Maison 276 is changing the narrative on aging, building community and scaling with support from J.P. Morgan.
Banking
Financial sponsors reshape packaging sector with scaled platforms and complex financing
May 28, 2026
Cross-border execution and creative capital structures are driving a new era of packaging M&A and financing.
Banking
How your operating account structure can improve liquidity
May 27, 2026
Your operating account does more than process payments; it determines how well you can see, protect and deploy your cash. Here’s how to structure it for better liquidity.
6:33 - Mergers & Acquisitions
The Paramount-Warner Bros. merger
May 26, 2026
Fred Turpin, Global Chair of Investment Banking at JPMorganChase, shares the details of the 18-month journey of the Paramount and Warner Brothers Discovery acquisition deal, and how he and his team navigated complex negotiations, uncertain terms and ever-changing scenarios to deliver for our client.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.